AI Prospecting for Cardinal Health

Cardinal Health has announced the acquisition of two companies: a majority stake in GI Alliance, a leading gastroenterology management services organization, for approximately $2.8 billion, and the Advanced Diabetes Supply Group for $1.1 billion. These acquisitions aim to accelerate growth in Cardinal Health's multi-specialty and at-Home Solutions segments[1]. Additionally, Cardinal Health has completed the acquisition of Integrated Oncology Network (ION), integrating over 100 providers across 10 states into its Navista oncology practice alliance[2].

Cardinal Health reported its first quarter fiscal year 2025 results, showing a 4% revenue decrease to $52.3 billion, but a 15% revenue increase excluding the impact of a large customer contract expiration. Non-GAAP operating earnings rose 12% to $625 million, driven by growth in the Pharmaceutical and Specialty Solutions segment. The company raised its fiscal 2025 guidance for non-GAAP diluted EPS to $7.75 to $7.90[1].

Cardinal Health has completed the acquisition of Integrated Oncology Network (ION), integrating more than 100 providers across 10 states into its Navista oncology practice alliance, enhancing its oncology care services[2].